These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 12115513)
1. NS-398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines. Cheng J; Imanishi H; Amuro Y; Hada T Int J Cancer; 2002 Jun; 99(5):755-61. PubMed ID: 12115513 [TBL] [Abstract][Full Text] [Related]
2. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398. Bae SH; Jung ES; Park YM; Kim BS; Kim BK; Kim DG; Ryu WS Clin Cancer Res; 2001 May; 7(5):1410-8. PubMed ID: 11350912 [TBL] [Abstract][Full Text] [Related]
3. Induction of G0/G1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interference. Denkert C; Fürstenberg A; Daniel PT; Koch I; Köbel M; Weichert W; Siegert A; Hauptmann S Oncogene; 2003 Nov; 22(54):8653-61. PubMed ID: 14647459 [TBL] [Abstract][Full Text] [Related]
4. Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells. Cheng AS; Chan HL; Leung WK; Wong N; Johnson PJ; Sung JJ Int J Oncol; 2003 Jul; 23(1):113-9. PubMed ID: 12792783 [TBL] [Abstract][Full Text] [Related]
5. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor. Hu KQ; Yu CH; Mineyama Y; McCracken JD; Hillebrand DJ; Hasan M Int J Oncol; 2003 Apr; 22(4):757-63. PubMed ID: 12632065 [TBL] [Abstract][Full Text] [Related]
6. Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells. Li J; Chen X; Dong X; Xu Z; Jiang H; Sun X J Gastroenterol Hepatol; 2006 Dec; 21(12):1814-20. PubMed ID: 17074019 [TBL] [Abstract][Full Text] [Related]
7. A selective cyclooxygenase-2 inhibitor, NS-398, inhibits cell growth by cell cycle arrest in a human malignant fibrous histiocytoma cell line. Yamashita H; Osaki M; Honjo S; Yoshida H; Teshima R; Ito H Anticancer Res; 2003; 23(6C):4671-6. PubMed ID: 14981912 [TBL] [Abstract][Full Text] [Related]
8. Dose-dependent modulation of apoptosis and cyclooxygenase-2 expression in human 1547 osteosarcoma cells by NS-398, a selective cyclooxygenase-2 inhibitor. Moalic S; Liagre B; Le Bail JC; Beneytout JL Int J Oncol; 2001 Mar; 18(3):533-40. PubMed ID: 11179483 [TBL] [Abstract][Full Text] [Related]
9. Specific COX-2 inhibitor NS398 induces apoptosis in human liver cancer cell line HepG2 through BCL-2. Huang DS; Shen KZ; Wei JF; Liang TB; Zheng SS; Xie HY World J Gastroenterol; 2005 Jan; 11(2):204-7. PubMed ID: 15633216 [TBL] [Abstract][Full Text] [Related]
10. Selective COX-2 inhibitor, NS-398, suppresses cellular proliferation in human hepatocellular carcinoma cell lines via cell cycle arrest. Baek JY; Hur W; Wang JS; Bae SH; Yoon SK World J Gastroenterol; 2007 Feb; 13(8):1175-81. PubMed ID: 17451196 [TBL] [Abstract][Full Text] [Related]
11. Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs. Lee DW; Sung MW; Park SW; Seong WJ; Roh JL; Park B; Heo DS; Kim KH Anticancer Res; 2002; 22(4):2089-96. PubMed ID: 12174888 [TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772 [TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis. Leng J; Han C; Demetris AJ; Michalopoulos GK; Wu T Hepatology; 2003 Sep; 38(3):756-68. PubMed ID: 12939602 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells. Li S; Tong Q; Zhang W; Wang Q; Chen Z; Wu Q Cancer Invest; 2008 May; 26(4):333-7. PubMed ID: 18443952 [TBL] [Abstract][Full Text] [Related]
15. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study]. Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595 [TBL] [Abstract][Full Text] [Related]
16. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate. Crew TE; Elder DJ; Paraskeva C Carcinogenesis; 2000 Jan; 21(1):69-77. PubMed ID: 10607736 [TBL] [Abstract][Full Text] [Related]
17. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Elder DJ; Halton DE; Hague A; Paraskeva C Clin Cancer Res; 1997 Oct; 3(10):1679-83. PubMed ID: 9815550 [TBL] [Abstract][Full Text] [Related]
18. Inhibitor of cyclooxygenase-2 induces cell-cycle arrest in the epithelial cancer cell line via up-regulation of cyclin dependent kinase inhibitor p21. Toyoshima T; Kamijo R; Takizawa K; Sumitani K; Ito D; Nagumo M Br J Cancer; 2002 Apr; 86(7):1150-6. PubMed ID: 11953864 [TBL] [Abstract][Full Text] [Related]
19. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis. Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of the expression of alpha-smooth muscle actin in human hepatic stellate cell line, LI90, by a selective cyclooxygenase 2 inhibitor, NS-398. Cheng J; Imanishi H; Liu W; Iwasaki A; Ueki N; Nakamura H; Hada T Biochem Biophys Res Commun; 2002 Oct; 297(5):1128-34. PubMed ID: 12372403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]